Ratings
0
Nobody has rated this yet. Be the first!
Works
8
Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates.
An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors
Structural basis for high-affinity HER2 receptor binding by an engineered protein
A trigger squeezed
Diverse somatic mutation patterns and pathway alterations in human cancers
Endocytosis and sorting of ErbB2 and the site of action of cancer therapeutics trastuzumab and geldanamycin
Structural and mechanistic insight into how antibodies inhibit serine proteases.
Phage-displayed antibody libraries of synthetic heavy chain complementarity determining regions
